Proteon Therapeutics, Inc. (PRTO)

[Whalatane]

Thx I asked poster Poorgrad on Dew's board to take a look at the final P 3 .
He argued ( and was right ) that the earlier trials would fail ....so it'll be interesting to see if the design of the final P 3 changes his opinion .
I sent him the Feb 2019 link and noted

Whereas vonapanitase did not meet its primary end point, there were several clinically meaningful indicators that vonapanitase may be an effective therapy in fistula creation. Importantly, vonapanitase was associated with increases in secondary patency and use of the fistula for hemodialysis. [/I].......and that former secondary and tertiary endpts were now co primary endpts

Will update you on his view , if he posts it .
Thx again for suggesting that I re examine PRTO
Kiwi